If Endo takes over Auxilium, more job cuts are likely for Philly-area pharma workers

Comment icon 0 Comments
Chesterbrook-based drugmaker Auxilium Pharmaceuticals responded Wednesday to the unsolicited takeover offer from Endo International, P.L.C... Read more

Merck gets FDA approval for new anti PD-1 cancer drug

Comment icon 0 Comments
This is a big day for Merck, which got fast-track approval from the U.S. Food and Drug Administration for a new drug to fight cancer. The FDA... Read more

Fewer blockbuster drugs help slow growth rate of U.S. healthcare costs - for now

Comment icon 0 Comments
The serious number crunchers at the Centers for Medicare and Medicaid Services released their latest projections for U.S. healthcare spending... Read more

Auxilium merges with Canadian biotech QLT for tax purposes

Comment icon 0 Comments
Chesterbrook-based Auxilium Pharmaceuticals said Thursday it would merge with Canadian biotech company QLT, in a $345 million stock deal designed... Read more

Do you deliver? Trying to sell more meds, AstraZeneca will host Twitter Chat on home delivery

Comment icon 0 Comments
Mail order medicine is old news. But big pharma's attempts to squeeze every last nickel out of its top selling drugs now includes home delivery... Read more

PA Bio cranks up the pharma and biotech lobbying in Harrisburg

Comment icon 0 Comments
Life sciences companies are like most other organizations and people: They like government when it does things for them and they dislike government... Read more

AbbVie CEO says the $46.5 billion offer is 'compelling' for Shire shareholders

Comment icon 0 Comments
AbbVie chief executive officer Richard Gonzalez told financial analysts Wednesday that his company's $46.5 billion offer for Shire, Plc., is... Read more

Merck reaches to Australia (again) for licensing deal

Comment icon 0 Comments
Merck's efforts to re-organize and re-energize itself to boost production of profitable medicine has included more licensing deals with smaller... Read more